These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10616177)

  • 41. Vaccines based on recombinant antigen strategies.
    Minor P
    Dev Biol (Basel); 2001; 105():189-94. PubMed ID: 11763327
    [No Abstract]   [Full Text] [Related]  

  • 42. The pathogenesis of poliomyelitis: what we don't know.
    Nathanson N
    Adv Virus Res; 2008; 71():1-50. PubMed ID: 18585526
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantifying low-frequency revertants in oral poliovirus vaccine using next generation sequencing.
    Sarcey E; Serres A; Tindy F; Chareyre A; Ng S; Nicolas M; Vetter E; Bonnevay T; Abachin E; Mallet L
    J Virol Methods; 2017 Aug; 246():75-80. PubMed ID: 28456668
    [TBL] [Abstract][Full Text] [Related]  

  • 44. WHO Expert Committee on Biological Standardization.
    World Health Organ Tech Rep Ser; 2002; 910():1-104, back cover. PubMed ID: 15497598
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Live attenuated oral poliovirus vaccine: problem areas in production.
    Beale AJ
    Rev Infect Dis; 1984; 6 Suppl 2():S334. PubMed ID: 6429813
    [No Abstract]   [Full Text] [Related]  

  • 46. Virology. Poliomyelitis eradication--a dangerous endgame.
    Nathanson N; Fine P
    Science; 2002 Apr; 296(5566):269-70. PubMed ID: 11951020
    [No Abstract]   [Full Text] [Related]  

  • 47. Infectious diseases. Polio outbreak raises questions about vaccine.
    Greensfelder L
    Science; 2000 Dec; 290(5498):1867-9. PubMed ID: 11187033
    [No Abstract]   [Full Text] [Related]  

  • 48. Oral poliovaccine: will it help eradicate polio or cause the next epidemic?
    Shulman LM; Manor Y; Sofer D; Swartz T; Mendelson E
    Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Problems in producing some antiviral preparations].
    Grachev VP; Mironova LL; Drozdov SG; Avdeeva LI; Popova VD
    Vestn Akad Med Nauk SSSR; 1977; (5):11-7. PubMed ID: 407738
    [No Abstract]   [Full Text] [Related]  

  • 50. [Intense campaign for vaccination with the oral polio vaccine: what are the repercussions on the enterovirus world?].
    Delpeyroux F; Guillot S; Szendröi A; Balanant J; Caro V; Cuervo N; Chevaliez S; Dahourou G; Crainic R
    Bull Soc Pathol Exot; 2000 Jul; 93(3):193-7. PubMed ID: 11030056
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of mutational pattern in 5'-NCR and VP1 regions of polioviruses for molecular diagnosis.
    Pliaka V; Dedepsidis E; Kyriakopoulou Z; Papadopoulou I; Levidiotou S; Markoulatos P
    Mol Cell Probes; 2007 Aug; 21(4):267-75. PubMed ID: 17336496
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interrupting wild poliovirus transmission using oral poliovirus vaccine: environmental surveillance in high-risks area of India.
    Chowdhary R; Dhole TN
    J Med Virol; 2008 Aug; 80(8):1477-88. PubMed ID: 18551602
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Live oral poliovirus vaccines do not contain detectable simian virus 40 (SV40) DNA.
    Sierra-Honigmann A; Krause PR
    Biologicals; 2000 Mar; 28(1):1-4. PubMed ID: 10799049
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication.
    Minor P
    Vaccine; 2009 May; 27(20):2649-52. PubMed ID: 19428874
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Studies on the attenuation phenotype of polio vaccines: poliovirus RNA polymerase derived from Sabin type 1 sequence is temperature sensitive in the uridylylation of VPg.
    Paul AV; Mugavero J; Yin J; Hobson S; Schultz S; van Boom JH; Wimmer E
    Virology; 2000 Jun; 272(1):72-84. PubMed ID: 10873750
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genomic features of intertypic recombinant sabin poliovirus strains excreted by primary vaccinees.
    Cuervo NS; Guillot S; Romanenkova N; Combiescu M; Aubert-Combiescu A; Seghier M; Caro V; Crainic R; Delpeyroux F
    J Virol; 2001 Jul; 75(13):5740-51. PubMed ID: 11390576
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polio eradication, cessation of vaccination and re-emergence of disease.
    Minor PD
    Nat Rev Microbiol; 2004 Jun; 2(6):473-82. PubMed ID: 15152203
    [No Abstract]   [Full Text] [Related]  

  • 59. Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961.
    Cutrone R; Lednicky J; Dunn G; Rizzo P; Bocchetta M; Chumakov K; Minor P; Carbone M
    Cancer Res; 2005 Nov; 65(22):10273-9. PubMed ID: 16288015
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Vaccination strategies for the global eradication of poliomyelitis].
    Bompart F
    Bull Soc Pathol Exot; 2004 Nov; 97(4):288-92. PubMed ID: 17304754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.